Literature DB >> 10563668

Helicobacter pylori infection in interleukin-4-deficient and transgenic mice.

W Chen1, D Shu, V S Chadwick.   

Abstract

BACKGROUND: Interleukin (IL)-4 is a potent anti-inflammatory and Th2-type immunoregulatory cytokine. Helicobacter pylori infection in humans induces a polarized Th1 immune response characterized by increased production of interferon-gamma and absence of IL-4. This study was designed to determine the role of endogenous IL-4 in the host defence against gastric colonization by H. pylori using IL-4-deficient (IL-4-/-) and transgenic (IL-4 Tg) mice.
METHODS: IL-4-/- mice and IL-4 Tg mice were inoculated intragastrically with H. pylori Sydney Strain 1. Gastric colonization by H. pylori (biopsy urease test and bacterial colony counts), serum levels of H. pylori-specific immunoglobulin M, A, G, isotypes of IgG, and the gastric mucosal inflammatory scores were determined 6 weeks after inoculation. Results were compared with those obtained from H. pylori-infected IL-4+/+ (controls for IL-4-/- mice) and IL-4 WT (controls for IL-4 Tg) mice.
RESULTS: Colonization of the gastric mucosa by H. pylori in IL-4-/- mice was similar to that of control IL-4+/+ mice. There was no significant difference in titres of H. pylori-specific antibodies or gastric inflammatory scores between the two groups of mice. Colonization of gastric mucosa by H. pylori was consistently lower in IL-4 Tg mice (log10 6.40+/-1.09 CFU/g tissue) compared with IL-4WT mice (log10 7.20+/-0.34 CFU/g tissue), although the difference was not significant. Nevertheless, IL-4 Tg mice did have significantly higher titres of H. pylori-specific IgA and IgG (P< or =0.01).
CONCLUSION: These results show that endogenous IL-4 is not a major contributor to host resistance to H. pylori, and enhanced IL-4 production has little if any effect on gastric colonization by this organism, despite increased specific antibody production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563668     DOI: 10.1080/003655299750025084

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

Review 1.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Immunity against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and gender of infected mice.

Authors:  T Aebischer; S Laforsch; R Hurwitz; F Brombacher; T F Meyer
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Role of tumor necrosis factor alpha in Helicobacter pylori gastritis in tumor necrosis factor receptor 1-deficient mice.

Authors:  Ulrike Thalmaier; Norbert Lehn; Klaus Pfeffer; Manfred Stolte; Michael Vieth; Wulf Schneider-Brachert
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Authors:  Yana Zavros; Sivaprakash Rathinavelu; John Y Kao; Andrea Todisco; John Del Valle; Joel V Weinstock; Malcolm J Low; Juanita L Merchant
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

5.  Effect of bacterial flora on postimmunization gastritis following oral vaccination of mice with Helicobacter pylori heat shock protein 60.

Authors:  Hiroyuki Yamaguchi; Takako Osaki; Haruhiko Taguchi; Noriko Sato; Atushi Toyoda; Motomichi Takahashi; Masanori Kai; Noboru Nakata; Akio Komatsu; Yutaka Atomi; Shigeru Kamiya
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

6.  Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4.

Authors:  Christine A Garhart; John G Nedrud; Frederick P Heinzel; Norma E Sigmund; Steven J Czinn
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection.

Authors:  Alicia R Mathers; Christopher F Cuff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

8.  Role of ASC in the mouse model of Helicobacter pylori infection.

Authors:  Bekale N Benoit; Motohiro Kobayashi; Masatomo Kawakubo; Michiko Takeoka; Kenji Sano; Jian Zou; Naoki Itano; Hiroko Tsutsui; Tetsuo Noda; Minoru Fukuda; Jun Nakayama; Shun'ichiro Taniguchi
Journal:  J Histochem Cytochem       Date:  2008-12-08       Impact factor: 2.479

9.  The interleukin-17 receptor B subunit is essential for the Th2 response to Helicobacter pylori, but not for control of bacterial burden.

Authors:  Dennis J Horvath; Jana N Radin; Sung Hoon Cho; M Kay Washington; Holly M Scott Algood
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.